These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 32948189)

  • 1. A qualitative study of perceived barriers to hepatitis C care among people who did not attend appointments in the non-urban US South.
    Sherbuk JE; Tabackman A; McManus KA; Kemp Knick T; Schexnayder J; Flickinger TE; Dillingham R
    Harm Reduct J; 2020 Sep; 17(1):64. PubMed ID: 32948189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient and healthcare provider experiences of hepatitis C treatment with direct-acting antivirals in Rwanda: a qualitative exploration of barriers and facilitators.
    Serumondo J; Penkunas MJ; Niyikora J; Ngwije A; Kiromera A; Musabeyezu E; Umutesi J; Umuraza S; Musengimana G; Nsanzimana S
    BMC Public Health; 2020 Jun; 20(1):946. PubMed ID: 32546216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Motivations, facilitators and barriers to accessing hepatitis C treatment among people who inject drugs in two South African cities.
    Versfeld A; McBride A; Scheibe A; Spearman CW
    Harm Reduct J; 2020 Jun; 17(1):39. PubMed ID: 32522210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The common sense model applied to hepatitis C: a qualitative analysis of the impact of disease comparison and witnessed death on hepatitis C illness perception.
    Safo SA; Batchelder A; Peyser D; Litwin AH
    Harm Reduct J; 2015 Jun; 12():20. PubMed ID: 26092261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using an intersectionality lens to explore barriers and enablers to hepatitis C point-of-care testing: a qualitative study among people who inject drugs and service providers.
    Fontaine G; Presseau J; Bruneau J; Etherington C; Thomas IM; Hung JC; van Allen Z; Patey AM; Kareem A; Mortazhejri S; Høj SB; Boyer-Legault G; Grimshaw JM
    Int J Equity Health; 2024 Jun; 23(1):124. PubMed ID: 38886803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enablers and barriers for the provision of community-based HCV treatment: A case study of a real-world practice.
    Pourmarzi D; Smirnov A; Hall L; Thompson H; FitzGerald G; Rahman T
    J Viral Hepat; 2020 May; 27(5):484-496. PubMed ID: 31958355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clients' perceptions of barriers and facilitators to implementing hepatitis C virus care in homeless shelters.
    Masson CL; Fokuo JK; Anderson A; Powell J; Zevin B; Bush D; Khalili M
    BMC Infect Dis; 2020 May; 20(1):386. PubMed ID: 32471376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 'Hep C's like the common cold': understanding barriers along the HCV care continuum among young people who inject drugs.
    Skeer MR; Ladin K; Wilkins LE; Landy DM; Stopka TJ
    Drug Alcohol Depend; 2018 Sep; 190():246-254. PubMed ID: 30071457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Applying a stigma and time framework to facilitate equitable access to hepatitis C care among women who inject drugs: The ETHOS Engage Study.
    Marshall AD; Rance J; Dore GJ; Grebely J; Treloar C
    Int J Drug Policy; 2024 Jul; 129():104477. PubMed ID: 38861842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health care-seeking experiences for people who inject drugs with hepatitis C: Qualitative explorations of stigma.
    Austin EJ; Tsui JI; Barry MP; Tung E; Glick SN; Ninburg M; Williams EC
    J Subst Abuse Treat; 2022 Jun; 137():108684. PubMed ID: 34911656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using the barriers and facilitators to linkage to HIV care to inform hepatitis C virus (HCV) linkage to care strategies for people released from prison: Findings from a systematic review.
    Yanes-Lane M; Dussault C; Linthwaite B; Cox J; Klein MB; Sebastiani G; Lebouché B; Kronfli N
    J Viral Hepat; 2020 Feb; 27(2):205-220. PubMed ID: 31638294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "I want to feel young again": experiences and perspectives of young people who inject drugs living with hepatitis C in Vancouver, Canada.
    Jacob J; Goodyear T; Coulaud PJ; Hoong P; Ti L; Knight R
    Can J Public Health; 2021 Oct; 112(5):947-956. PubMed ID: 34115340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving access to care for people who inject drugs: Qualitative evaluation of project ITTREAT-An integrated community hepatitis C service.
    Phillips C; Schulkind J; O'Sullivan M; Edelman N; Smith HE; Verma S; Jones CJ
    J Viral Hepat; 2020 Feb; 27(2):176-187. PubMed ID: 31566851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Case-finding for hepatitis C in primary care: a mixed-methods service evaluation.
    Datta S; Horwood J; Hickman M; Sharp D
    Br J Gen Pract; 2014 Feb; 64(619):e67-74. PubMed ID: 24567619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C care continuum and associated barriers among people who inject drugs in Chennai, India.
    Patel EU; Solomon SS; Mcfall AM; Srikrishnan AK; Pradeep A; Nandagopal P; Laeyendecker O; Tobian AAR; Thomas DL; Sulkowski MS; Kumar MS; Mehta SH
    Int J Drug Policy; 2018 Jul; 57():51-60. PubMed ID: 29679811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HCV treatment access among Latinxs who inject drugs: qualitative findings from Boston, Massachusetts, 2016.
    Mittal A; Kosinski KC; Stopka TJ
    Harm Reduct J; 2019 Jul; 16(1):44. PubMed ID: 31288811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Barriers to and facilitators of hepatitis C testing, management, and treatment among current and former injecting drug users: a qualitative exploration.
    Swan D; Long J; Carr O; Flanagan J; Irish H; Keating S; Keaveney M; Lambert J; McCormick PA; McKiernan S; Moloney J; Perry N; Cullen W
    AIDS Patient Care STDS; 2010 Dec; 24(12):753-62. PubMed ID: 21138381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The challenges of hepatitis C management in Iran: A qualitative study with patients.
    Behzadifar M; Azari S; Gorji HA; Rezapour A; Bragazzi NL
    Int J Health Plann Manage; 2020 Jan; 35(1):e56-e65. PubMed ID: 31679166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 'Treat my whole person, not just my condition': qualitative explorations of hepatitis C care delivery preferences among people who inject drugs.
    Tsui JI; Barry MP; Austin EJ; Sweek EW; Tung E; Hansen RN; Ninburg M; Scott JD; Glick SN; Williams EC
    Addict Sci Clin Pract; 2021 Aug; 16(1):52. PubMed ID: 34384494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experiences of diagnosis, care and treatment among Aboriginal people living with hepatitis C.
    Brener L; Wilson H; Jackson LC; Johnson P; Saunders V; Treloar C
    Aust N Z J Public Health; 2016 Apr; 40 Suppl 1():S59-64. PubMed ID: 26123616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.